The current OCX market cap is 30.73M. The company's latest EPS is USD -3.4769 and P/E is -0.79.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 5.23M | 7.73M | 31.98M | 7.27M |
Operating Income | -22.52M | -31.26M | -74.48M | -18M | -23.85M |
Net Income | -22.43M | -29.93M | -64.1M | -73.42M | -28.72M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 39.86M | 55.42M | 159.56M | 100.09M | 74.89M |
Total Liabilities | 9.02M | 21.94M | 94.35M | 60.5M | 49.3M |
Total Equity | 30.84M | 33.48M | 65.22M | 34.29M | 20.47M |
Market Cap | 30.73M |
Price to Earnings Ratio | -0.79 |
Price to Sales Ratio | 3.14 |
Price to Cash Ratio | 2.42 |
Price to Book Ratio | 0.89 |
Dividend Yield | - |
Shares Outstanding | 8.26M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.19 (4.87%) |
Company Name | OncoCyte Corporation |
Address |
15 cushing irvine, california 92618 |
Website | https://www.oncocyte.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions